Don't agree with every point, but for the most par

Don't agree with every point, but for the most part, very interesting perspective. One thing we all agree on is that ICNB has a lot of potential and momentum should accelerate this week. Someone on the other board did the calculations for the next year of sales at 30,000 cases per month -- as per an email from Rich, and deduced that revenues at 6 bottles a case x $20.00 a bottle for 12 months will accrue more than $43 million in revenues. Even at $10.00 per bottle profit, this means the company will do exceptionally well in 2017. And, of course this translates into a higher share price and more money for us. This certainly has the potential to be a mega stock in the future, all things being equal.